• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Micronutrient supplementation linked with decreased HIV-disease progression

bys25qthea
November 28, 2013
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD 

1. Supplementation with multivitamin plus selenium decreased risk of developing a CD4 cell count of 350/μL in ART-naïve HIV-infected patients. 

2. Multivitamin plus selenium supplementation did not increase risk of HIV or health-related adverse events. 

Evidence Rating Level: 2 (Good)          

Study Rundown:  Despite its known efficacy, access to antiretroviral therapy (ART) is limited in resource poor settings. Micronutrients such as B vitamins, vitamin C and E, and selenium are known to be a crucial component of a robust immune system. Previous research has shown that micronutrient supplementation increased CD4 count and decreased viral load in late stages of HIV infection. This study examined the effect of certain micronutrient supplements on immune function and disease progression in the early stages of HIV. The authors found that supplementation with a single daily pill of multivitamin plus selenium significantly reduced the risk of developing a CD4 count of 350/μL and a combined outcome of CD4 <350/μL, AIDS-defining conditions, or AIDS-related death compared to placebo. Micronutrient supplementation did not increase the risk of adverse events and was determined to be safe. This study was performed in a resource poor setting and in patients with HIV-subtype C, which is known to accelerate disease progression. Overall, these findings provide support for an effective alternative intervention to prevent early HIV disease progression in areas where ART is not readily available.

Click to read the study in JAMA

Relevant Reading:  Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy

RELATED REPORTS

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

Several factors influence health programs conducted in the African American Church

Liposomal amphotericin B noninferior to standard treatment for cryptococcal meningitis

In-Depth [randomized controlled trial]: This double blind, placebo controlled clinical trial randomized 878 HIV subtype C-infected, ART-naïve Botswanan adults with CD4 cell count greater than 350/μL into four study groups. Each group received a single daily pill of multivitamin alone, selenium alone, multivitamin plus selenium, or placebo. Participants were assessed every 3 months for an average total duration of 24 months. Treatment with multivitamin plus selenium (p=0.02, HR 0.48, 95% CI: 0.26-0.88) and multivitamin alone (p=0.04, HR 0.54, 95% CI: 0.30-0.98) significantly reduced the risk of developing a CD4 count of 250/μL or less while selenium alone had no effect (p=0.50, HR 0.83, 95% CI: 0.48-1.42). Multivitamin plus selenium supplementation also significantly reduced the risk of obtaining the composite outcome of CD4 <350/μL, AIDS-defining conditions, or AIDS-related death (p = 0.045, HR 0.65, 95% CI: 0.43-0.99). HIV viral load was not significantly different between any of the study groups. Of 78 participants, 79 serious adverse advents were reported, none of which were deemed related to the intervention. No significant differences in HIV-related and health related adverse events were found between the four groups.

By Jonathan Lichkus and Rif Rahman

More from this author: Obesity without metabolic syndrome still associated with increased mortality, Childhood poverty may harm brain development, Prostate-Specific Antigen screening of elderly men varies significantly in primary care, Younger women more likely than men to present with acute coronary syndrome without chest pain

© 2012-2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: AIDSHIVsupplementationsupplements
Previous Post

Hypercortisolism of bilateral macronodular adrenal hyperplasia may be corticotropin-dependent

Next Post

The RIVAL trial: Radial vs femoral artery access for PCI [Classics Series]

RelatedReports

Gardasil vaccine demonstrates immunogenic response at 10-year follow-up
Chronic Disease

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

May 18, 2022
Wellness

Several factors influence health programs conducted in the African American Church

May 18, 2022
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Chronic Disease

Liposomal amphotericin B noninferior to standard treatment for cryptococcal meningitis

March 29, 2022
Increased frailty associated with childhood cancer survivorship
Oncology

Pembrolizumab as a promising treatment in patients with classic or endemic Kaposi’s sarcoma

March 27, 2022
Next Post

The RIVAL trial: Radial vs femoral artery access for PCI [Classics Series]

ARMC5 mutation identified in patients with macronodular adrenal hyperplasia

ARMC5 mutation identified in patients with macronodular adrenal hyperplasia

Mortality risk higher in pediatric trauma patients with chronic conditions

Surgical ward rounds “quality” correlates with outcomes, complications

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.